Basil Krikelis (’95) Says Biotech-Pharma Innovation Requires Specialized Patent Counsel

May 20 – The Metropolitan Corporate Counsel

Basil S. Krikelis (JD ’95) featured

After two years in private practice, I accepted an offer from another DuPont joint venture, DuPont-ConAgra, to serve as in-house patent counsel, which I did for five years, two of those years as chief patent counsel. My responsibilities included managing a patent estate of approximately 500 U.S. and foreign patents that were directed primarily to animal feed and welfare applications and with plant and other related biotech technology.

Read more: Biotech-Pharma Innovation Requires Specialized Patent Counsel

Cookie Settings